Skip to main content
Premium Trial:

Request an Annual Quote

Ginkgo Bioworks, Syngenta Seeds Strike Research Deal for Plant Trait Development

NEW YORK — Ginkgo Bioworks has formed a partnership with Syngenta Seeds focused on the discovery of new traits for seed development, the companies said on Monday.

Under the terms of the deal, Ginkgo and Syngenta will screen a targeted genetic library for novel traits. The alliance will combine Ginkgo's protein engineering capabilities and proprietary ultra-high-throughput screening technologies with Syngenta's expertise in plant trait design and development, the firms said.

Financial and other terms were not disclosed.

"We are excited to leverage our proprietary ultra-high-throughput single-cell encapsulation and screening platform to support Syngenta's development efforts to bring the next generation of innovative products to farmers," Magalie Guilhabert, VP and head of ag biologicals at Ginkgo, said in a statement.

Ginkgo offers services for developing and optimizing the manufacture of chemical products using synthetic biology. About a year ago, the Boston-based company acquired an agricultural biologicals site from Bayer as part of an arrangement between the companies to research microbe-based nitrogen fixation.

The Scan

Cystatin C Plays Role in Immunosuppression, Cancer Immunotherapy Failure, Study Finds

A study in Cell Genomics provides insight into how glucocorticoids can lead to cancer immunotherapy failure via cystatin C production.

Aging, Species Lifespan Gene Expression Signatures Overlap

An Osaka Metropolitan University team reports in Nucleic Acids Research that transcriptional signatures of aging and maximum lifespan have similarities.

Splicing Subgroup Provides Protocols for Evaluating Splicing Variant Data

The group presents their approach on how to apply evidence codes to splicing predictions and other data in the American Journal of Human Genetics.

Single-Cell Transcriptomic Atlas of Mouse Cochlea to Aid Treatment Development

Researchers in PNAS conducted single-cell and single-nuclear sequencing of about 120,000 cells at three key timepoints in cochlear development to generate a transcriptomic atlas.